These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603 [TBL] [Abstract][Full Text] [Related]
3. Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS). Furusyo N; Takeoka H; Toyoda K; Murata M; Maeda S; Ohnishi H; Fukiwake N; Uchi H; Furue M; Hayashi J Eur J Dermatol; 2007; 17(5):397-404. PubMed ID: 17673383 [TBL] [Abstract][Full Text] [Related]
4. Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis. Furue M; Matsumoto T; Yamamoto T; Takeuchi S; Esaki H; Chiba T; Yamaguchi H J Dermatol Sci; 2012 Apr; 66(1):60-3. PubMed ID: 22391243 [TBL] [Abstract][Full Text] [Related]
5. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816 [TBL] [Abstract][Full Text] [Related]
6. [Biomarker of atopic dermatits -focusing on serum TARC/CCL17 level as severity marker-]. Saeki H Arerugi; 2013 Feb; 62(2):131-7. PubMed ID: 23531648 [No Abstract] [Full Text] [Related]
7. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834 [TBL] [Abstract][Full Text] [Related]
8. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels. Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186 [TBL] [Abstract][Full Text] [Related]
9. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis. Song TW; Sohn MH; Kim ES; Kim KW; Kim KE Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646 [TBL] [Abstract][Full Text] [Related]
10. Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis. Kwakkel-van Erp JM; Haeck IM; Paantjens AW; van de Graaf EA; van Ginkel WG; Knol MJ; de Bruin-Weller MS; Lammers JW; Knol EF; Bruijnzeel-Koomen C; Otten HG J Am Acad Dermatol; 2010 Sep; 63(3):e70-2. PubMed ID: 20708466 [No Abstract] [Full Text] [Related]
11. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451 [TBL] [Abstract][Full Text] [Related]
12. [Objective measurements of disease severity and diagnostic confirmation in atopic dermatitis and urticaria]. Mihara S Arerugi; 2012 Jan; 61(1):10-7. PubMed ID: 22398423 [No Abstract] [Full Text] [Related]
13. Variations in serum TARC and I-TAC levels reflect minor changes in disease activity and pruritus in atopic dermatitis. Kimura T; Sugaya M; Suga H; Morimura S; Miyamoto A; Kai H; Kagami S; Yanaba K; Fujita H; Asano Y; Tada Y; Kadono T; Sato S Acta Derm Venereol; 2014 May; 94(3):331-2. PubMed ID: 24104601 [No Abstract] [Full Text] [Related]
14. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957 [TBL] [Abstract][Full Text] [Related]
15. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis. Kataoka Y J Dermatol; 2014 Mar; 41(3):221-9. PubMed ID: 24628072 [TBL] [Abstract][Full Text] [Related]
16. Serum TARC and CTACK concentrations in children with atopic dermatitis, allergic asthma, and urticaria. Machura E; Rusek-Zychma M; Jachimowicz M; Wrzask M; Mazur B; Kasperska-Zajac A Pediatr Allergy Immunol; 2012 May; 23(3):278-84. PubMed ID: 22017510 [TBL] [Abstract][Full Text] [Related]
17. Expression of thymus and activation-regulated chemokine (TARC) by human dermal cells, but not epidermal keratinocytes. Shoda T; Futamura K; Kobayashi F; Saito H; Matsumoto K; Matsuda A J Dermatol Sci; 2014 Nov; 76(2):90-5. PubMed ID: 25219597 [TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children. Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706 [TBL] [Abstract][Full Text] [Related]
19. Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice. Vestergaard C; Deleuran M; Gesser B; Larsen CG Exp Dermatol; 2004 Apr; 13(4):265-71. PubMed ID: 15086343 [TBL] [Abstract][Full Text] [Related]
20. An ultra-sensitive clinical biomarker assay: quantitation of thymus and activation-regulated chemokine in human plasma. Zhao X; Delgado L; Weiner R; Laterza OF Bioanalysis; 2014 Apr; 6(8):1069-80. PubMed ID: 24830891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]